Nordion Settles Dr. Reddy's $80M Negligent Testing Suit

Law360, New York (March 22, 2013, 1:51 PM EDT) -- Medical equipment and research company Nordion Inc. said Thursday it has agreed to settle a lawsuit in New Jersey federal court in which Dr. Reddy’s Laboratories Inc. claimed poor testing conditions at a Nordion unit’s laboratories cost it more than $80 million in retesting and delayed and abandoned generic drug approvals.

The deal ends claims that Nordion's former business unit MDS Pharma Services Inc. failed to maintain good laboratory practices at two of its facilities, costing Dr. Reddy's $80 million in lost profits and retesting costs...
To view the full article, register now.